- Referral to the Breast Clinic
- Breast Reconstruction
- Breast Cancer Surgery
Mr Giles Davies is the Director of Surgery at the Prestigious Cromwell Hospital, an International Centre of Excellence fro Breast Cancer Care and the Specialist Centre for BUPA Nationally for Breast Cancer in the BUPA Network.
Mr Giles Davies MB BS BSc. MD FRCS(Gen.Surg.) was educated at Harrow school and subsequently trained at St Georges Hospital Medical school where he obtained the Wiliam Devitt-Pendulbury exhibition for outstanding achievement in part B MB BS.
He graduated with an intercalated BSc with honours and undertook basic surgical training at the Royal London Hospital and then specialist surgical training in the South West Thames Specialist Registrar Rotation. During this training Mr Davies undertook a two year period of research at the Royal Marsden Hospital where he was awarded his MD Thesis.
His research on the prevention of breast cancer with COX-2 inhibitors has been widely published and he has presented research at international meetings in Australia, Japan and the USA. In 2006 he spent an international Oncoplastic Fellowship year at the Royal Adelaide Hospital in Australia as the Senior Registrar and Oncoplastic Fellow where he was trained in Oncoplastic surgical techniques of the breast.
In October 2007 Mr Davies was appointed as an Oncoplastic Breast Surgeon at the Kingston Hospital Breast Unit and also is an honorary Consultant Oncoplastic Breast Surgeon at the Royal Marsden Hospital in Fulham.
In 2014 Mr Davies became an Examiner at St Georges Hospital Medical School and also sits in the interview panel for National Core Surgical Training selection. More recently Mr Davies has reduced his NHS commitment to expand a research team based at Kingston University where there is now a thriving research group of 8 researchers investigation the link between the virus that causes cervical cancer Human Papillomavirus (HPV) and breast cancer. Mr Davies has recently presented in Qatar the first ever evidence of the presence of HPV in fresh breast cancer tissue and is currently supervising 2 PhD students researching this topic further.
The Clinical Impact of Oncoplastic and Reconstructive Procedures in a Specialist Breast Practice. Kollias J, Bochner M, Davies G, Gill PG. Submitted for publication ANZ Journal of Surgery 2007
Surgeon performed ultrasound in combination with sestamibi; reliable preoperative investigations for surgeons planning MIP
Prasannan S., Davies G, Malycha P et al. Submitted for publication ANZ Journal of Surgery 2007
Erosive adenomatosis of the nipple – a report of 3 cases. Davies G. et al. Annals of Royal College of Surgeons of England 2004: 86. 146-147
Cyclooxygenase-2 and chemoprevention of breast cancer. Davies G. J Steroid Biochemistry and Molecular Biology 2003 Sep;86(3-5):495-9
Correlation between cyclooxygnenase-2 expression and angiogenesis in human breast cancer. Davies G. et al. Clinical Cancer Research 2003 Jul;9(7):2651-6
Cyclooxygenase-2 (COX-2), aromatase and breast cancer: a possible role for COX-2 inhibition in breast cancer chemoprevention. Davies G. et al. Annals of Oncology 2002: 13
Jet-ski injury: severe blunt neck trauma with survival. Davies G. et al JRSM 2001 August: 94; 402-3
Effects of diadenosine phosphates on human umbilical vessels: novel platelet-derived vasoconstrictors. Davies G. et al. Brit. J. Clin. Pharm.: 1995; 40 : 170-172
“Sentinel lymph node biopsy in invasive breast cancer using 99mTc-Evans Blue dye.” G.Davies, M Green, J Kollias, G Gill, B Chatterton, C Tsopelas
Royal Australasian College of Surgeons 75th Annual Scientific Congress 15-19thMay 2006
“Cyclooxygenase-2 (COX-2) expression in human breast cancers – correlations with known biological variables and rationale for the use of COX-2 inhibitors” Davies G. et al. Poster and Discussion, American Society of Clinical Oncology, Orlando, Florida, USA 19th-23rd May 2002
“COX-2, biology and links with intratumoural aromatase” Invited oral presentation at Aromatase 2002 conference, Kyoto, Japan 26th-30th October 2002
“Current management of DCIS” Case presentation on behalf of the Academic Breast Unit Royal Marsden Hospital, 3rd European Breast Cancer Conference, Barcelona, Spain 2002
“Cyclooxygenase-2, aromatase and breast cancer: a possible role for COX-2 inhibitors in breast cancer chemoprevention”: Presented at 7th Nottingham International Breast Cancer Conference, November 2001
“Simplifying Sentinel Node Biopsy in Breast Cancer: Blue dye alone is accurate”: Presented at the Royal Australasian College of Surgeons Annual Scientific Congress, Canberra, Australia 2001 (published as abstract in ANZ Journal of Surgery vol 71, May 2001)
“COX-2: Neoadjuvant studies”: Presented at 2nd Pharmacia Oncology UK Forum 15th-17th November 2001
“Jet-ski injury”: Presented at London Group of Paediatric Surgeons, Great Ormond Street Childrens Hospital 1999
Mr Davies latest research update finds evidence of the presence of Human Papillomavirus (HPV) in breast cancer tissue
Presented in International Breast Cancer Immunotherapy Symposium Qatar 13th-14th April 2015
"Association of High Risk Human Papillomavirus (HPV) types with breast cancer: UK population based study"